A phase I study of fluzoparib tablet formulation, an oral PARP inhibitor: effect of food on the pharmacokinetics and metabolism after oral dosing in healthy Chinese volunteers

Wu, M; Li, XJ; Sun, JX; Chen, H; Ding, YH

Ding, YH (corresponding author), First Hosp Jilin Univ, Dept Phase Clin Trial Unit 1, Changchun 130021, Peoples R China.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, ; ():

Abstract

Objective To evaluate the effect of food on the pharmacokinetics (PK) of fluzoparib capsule. Methods PK data were obtained after fluzoparib treatment ......

Full Text Link